Delivery Order SPE2DB22D1202-SPE2DB24FVGP9

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,925.88 Firm Fixed Price delivery order is for the supply of topiramate extended-release 50 mg capsules, and has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of 4,564,510,598 units of Topiramate Extended Release 200 mg Capsules. The Firm Fixed Price Delivery Order has a ceiling value of $2,090.34 and an ultimate completion date of May 7, 2024. The contract is not set aside for any specific business classification. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,392.08 firm fixed price delivery order is for the supply of 30-count bottles of 100 mg topiramate extended-release capsules. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a Firm Fixed Price Delivery Order to provide Topiramate Extended Release 150 mg Capsules to support military treatment programs and facilities. The contract does not have a set-aside designation and has a total ceiling value of $1,111.40. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of topiramate extended-release 200 milligram capsules. The award is not set aside and has a ceiling value of $51,967.52. The contract is a firm-fixed-price type and has an ultimate completion date of July 29, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,531.57 firm fixed-price contract is for the supply of 100-count bottles of 100 mg topiramate extended-release capsules. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of topiramate extended-release 200 mg capsules. The contract has a period of performance through November 3, 2023 and a ceiling value of $12,842.53. It is a firm fixed-price delivery order contract and was not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Topiramate ER 100 mg capsules. The contract has a ceiling value of $5,317.56 and an ultimate completion date of April 12, 2023. This award is a delivery order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order worth $3,485.26 for the provision of Topiramate ER 50 mg capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,344.91 firm fixed-price delivery order is for the supply of 4,567,198 units of Topiramate 25 mg tablets. The contract, which has an ultimate completion date of February 10, 2025, does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVGP9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Topiramate Extended-Release 25mg capsules. The contract is a Delivery Order with a Firm Fixed Price of $2,373.38 and an ultimate completion date of July 12, 2024.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific contract award does not have a set-aside designation, indicating it was competed on a full and open basis. Amerisourcebergen, as a subsidiary of one of the largest pharmaceutical distribution companies globally, leverages its extensive supply chain network to efficiently fulfill government contracts for critical medical products.

Generated 10/10/24, 9:11 AM